Home

David Lamond, Director: Quince Therapeutics QNCX Buy · Filed 23/12/14

Trade details

Type
Insider buy
Amount
$23,532.08
Shares · price
22,627 sh · $1.04 a share
Held after
2,347,545 sh
Trade date
23/12/14
Filed
23/12/14
Days to filing
0 days

Holdings up 1.0%

Insiders buying this week
1 insiders
Holding change
+1.0%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/14~24/01/13

David Lamond's recent trades

  • David Lamond

    BuyQuince Therapeutics

    $22.8K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.6K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $300

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $19.5K

    Filed 23/12/07

  • David Lamond

    BuyQuince Therapeutics

    $19.3K

    Filed 23/12/07